In NSCLC specifically, recurrently mutated oncogenes and tumor suppressors (TP53, EGFR, KEAP1, and others) have been implicated as regulators of metabolism and major drivers of metabolic reprogramming (Table 1) (44). Here, EGFR is linked to non-small cell lung carcinoma.